Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus

Bone Marrow Transplantation

Volumn 48, Issue 4, 2013, Pages 544-550

  Li, X ^a   Wang, D ^a   Liang, J ^a   Zhang, H ^a   Sun, L ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

cytopenia; MSCs; systemic lupus erythematosus; Treg Th17

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOPENIA; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPHOCYTE COUNT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876420786     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.184     Document Type: Article

References (22)

1. Petri M. Systemic lupus erythematosus: 2006 update. J Clin Rheumatol 2006; 12: 37-40.
2. Pontikoglou C, Deschaseaux F, Sensebé L, Papadaki HA. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 2001; 7: 569-589.
3. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-3506.
4. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126.
5. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006; 24: 74-85.
6. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S et al. (2009) Mesenchymal stem cell transplantation reverses multi-organ dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27: 1421-1432.
7. Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008; 5: 417-424.
8. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2467-2475.
9. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010; 69: 1423-1429.
10. Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999; 8: 586-595.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
12. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586.
13. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood 2007; 110: 2764-2767.
14. Christopeit M, Schendel M, Föll J, Müller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008; 22: 1062-1064.
15. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells revert hyperglycaemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008; 14: 631-640.
16. Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006; 65: 144-148.
17. Wang D, Zhang H, Cao M, Tang Y, Liang J, Feng X et al. fficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant poly-myositis and dermatomyositis. Ann Rheum Dis 2011; 70: 1285-1288.
18. Roffe C, Cahill MR, Samanta A, Bricknell S, Durrant ST. Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol 1991; 30: 301-304.
19. Sumimoto S, Kawai M, Kasajima Y, Hamamoto T. Aplastic anemia associated with systemic lupus erythematosus. Am J Hematol 1991; 38: 329-331.
20. Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007; 317: 627-629.
21. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythe-matosus: current concepts. Clin Exp Immunol 2009; 157: 209-215.
22. Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 1472-1483.